Outset Medical (OM) Current Deferred Revenue (2019 - 2026)

Outset Medical (OM) has 8 years of Current Deferred Revenue data on file, last reported at $12.6 million in Q1 2026.

• On a quarterly basis, Current Deferred Revenue fell 4.15% year-over-year to $12.6 million in Q1 2026; TTM through Mar 2026 was $12.6 million, a 4.15% decrease from a year earlier, with the FY2025 full-year figure at $13.8 million, up 8.17% from the prior year.
• Current Deferred Revenue for Q1 2026 stood at $12.6 million, down from $13.8 million in the prior quarter.
• Over the last five years, Current Deferred Revenue for OM reached as high as $14.9 million in Q3 2025 and fell as low as $6.8 million in Q1 2022.
• Historically, Current Deferred Revenue has averaged $11.4 million across 5 years, with a median of $12.6 million in 2026.
• Across the five-year window, Current Deferred Revenue soared 93.02% in 2022 and fell 4.15% in 2026, its largest moves.
• Year by year, Current Deferred Revenue stood at $8.7 million in 2022, then soared by 35.38% to $11.7 million in 2023, then increased by 8.75% to $12.8 million in 2024, then grew by 8.17% to $13.8 million in 2025, then retreated by 8.37% to $12.6 million in 2026.
• Per Business Quant data, the three most recent Current Deferred Revenue figures were $12.6 million in Q1 2026, $13.8 million in Q4 2025, and $14.9 million in Q3 2025.